logo
  

Canadian Natural Resources Q4 Profit Rises - Quick Facts

Canadian Natural Resources Limited (CNQ.TO,CNQ) reported fourth-quarter net income of C$1.20 billion or C$1.09 per share, compared to C$413 million or C$0.38 per share, prior year. Adjusted net earnings from operations was C$756 million or C$0.69 per share, for the quarter.

On average, 11 analysts polled by Thomson Reuters expected the company to report profit per share of C$0.68 for the quarter. Analysts' estimates typically exclude special items.

Product sales increased to C$4.85 billion from C$4.33 billion last year. Revenue was C$4.38 billion, compared to C$3.95 billion. Analysts expected revenue of C$4.91 billion for the quarter.

Total crude oil and NGL production was approximately 572,000 bbl/d for the fourth quarter of 2014, an increase of 20% from prior year levels, resulting largely from increased crude oil and NGL production volumes across all business divisions. Total natural gas production was 1,733 MMcf/d, an increase of 45% from prior year level, largely due to acquisitions completed in the first half of the year and the concentrated liquids-rich Montney natural gas drilling program at Septimus.

The company announced that its capital guidance for 2015 has been reduced by C$150 million as a result of the reduction in scope of the originally planned 2015 Horizon maintenance turnaround from 35 days to 6 days.

As a result of the focus on cost control, the members of Canadian Natural's Management Committee have agreed to a 10% salary reduction, effective March 1, 2015. Concurrently, the Board of Directors has also agreed to reduce their annual Board cash retainer by 10%.

Canadian Natural Resources announced that its Board has declared a quarterly cash dividend on its common shares of C$0.23 per share. The dividend will be payable April 1, 2015 to shareholders of record at the close of business on March 16, 2015.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
French drug major Sanofi reported Thursday weak profit in its first quarter, despite higher net sales. The company also maintained its fiscal 2024 outlook. Sanofi shares were gaining around 4 percent in Paris trading as well as in pre-market activity on the Nasdaq. While reporting financial results for the first quarter on Wednesday, medical devices company Boston Scientific Corp. (BSX) raised its adjusted earnings and net sales growth guidance for the full-year 2024. For fiscal 2024, the company now projects earnings in a range of $1.43 to $1.48 per share and... Shares of Roche Holding AG were losing around 3 percent in Switzerland after the drug major reported weak sales in its first quarter and confirmed fiscal 2024 outlook. Excluding COVID-19-related products, quarterly sales increasedy 7 percent. For fiscal 2024, Roche continues to expect an increase in group sales in the mid single digit range at constant exchange rates.

This week, we feature Nigeria’s combat with meningitis, Hostile takeover bid for Vanda Pharma, US opioid crisis, Sammy’s Milk’s safety concerns, and X4’s Mavorixafor’s fast-track status.

View More Videos
Follow RTT